Pfizer posts loss of 3.12 billion euros on acquisition
Article Abstract:
Pfizer Inc. posted a $3.59 billion (3.12 billion euros) loss for the 2003 second quarter. The loss was caused mainly by the company's acquisition of Pharmacia Corp. in April 2003.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Pfizer nears a deal to acquire Angiosyn, pad eye-drug roster
Article Abstract:
Pfizer Inc. nears an acquisition of Angiosyn Inc., a California biotechnology company working on developing a medication to ward off blindness, for approximately $527 million.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Pfizer makes progress on diseases
Article Abstract:
Pfizer Inc.'s scientists have made progress in research on a series of old diseases. Pfizer scientists have made progress on the SARS virus, malaria, and on smallpox.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Italian deal brings 5.65 billion euros. Lloyds is near deal to sell bank in New Zealand. HSBC Holdings plans to sell off unit stake
- Abstracts: Pechiney SA. Alcan offers 3.4 billion euros to take over Pechiney. Corus to take its Dutch board to appeals court
- Abstracts: Infineon posts $69.6 million loss due to antitrust-related charge. Infineon loss widened in period
- Abstracts: Camillo Eitzen to acquire Songa. Evergreen Group to expand fleet
- Abstracts: Infineon posts wider net loss despite memory-chip gains. Siemens's earnings jump 29% on 4.6% increase in revenue: engineering firm expects to beat its full-year earnings targets